Simos Simeonidis

Simos Simeonidis is a Senior Analyst at Sarissa Capital Management LP based in New York, where he focuses on research, portfolio management, and shareholder activism in the healthcare sector. His investment expertise centers on biotechnology, biopharmaceuticals, and life sciences, with an emphasis on identifying innovation and growth opportunities within pharmaceutical and diagnostic companies.

Previously, Dr. Simeonidis held senior positions as Managing Director and Senior Biotech Analyst at RBC Capital Markets and at Cowen and Company, where he covered the biopharma sector, providing strategic insights for institutional clients on therapeutics and emerging medical technologies. He also brings experience as Associate Director of Business Development & Licensing at Novartis, and has been a faculty member at Harvard Medical School, focusing on gene expression research.

Dr. Simeonidis holds a PhD in Cellular, Molecular, and Biophysical Studies from Columbia University, completed a postdoctoral fellowship at Harvard Medical School, and earned an MBA in Healthcare Management from the Wharton School of the University of Pennsylvania. He is recognized as a thought leader in the biotech investment community, known for his rigorous scientific and industry analysis, and has contributed to public-private partnerships and venture formation in life sciences both in the U.S. and internationally.